The association between pre-exposure to glucocorticoids and other immunosuppressant drugs with severe COVID-19 outcomes

OBJECTIVES: Whether preinfection use of immunosuppressant drugs is associated with COVID-19 severity remains unclear. The study was aimed to determine the association between preinfection use of immunosuppressant drugs with COVID-19 outcomes within 1 month after COVID-19 diagnosis. METHODS: This coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Brodin, Rakel, van der Werff, Suzannes Desirée, Hedberg, Pontus, Färnert, Anna, Nauclér, Pontus, Bergman, Peter, Requena-Méndez, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135501/
https://www.ncbi.nlm.nih.gov/pubmed/35644344
http://dx.doi.org/10.1016/j.cmi.2022.05.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135501/
https://www.ncbi.nlm.nih.gov/pubmed/35644344
http://dx.doi.org/10.1016/j.cmi.2022.05.014

Ejemplares similares